tiprankstipranks
Trending News
More News >
Epigenomics (DE:ECX)
FRANKFURT:ECX
Germany Market

Epigenomics (ECX) Income Statement

Compare
1 Followers

Epigenomics Income Statement

See DE:ECX’s key income statement, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21
Total Revenue
€ 339.00K€ 485.00K€ 6.20M
Gross Profit
€ 282.00K€ 365.00K€ 6.07M
Operating Expenses
€ 4.46M€ 12.42M€ 8.42M
Depreciation and Amortization
€ 1.35M€ 749.00K€ 419.00K
EBITDA
€ -2.83M€ -11.22M€ -1.94M
Operating Income
€ -4.18M€ -12.05M€ -2.35M
Other Income/Expenses
€ -287.00K€ -50.00K€ -56.00K
Pretax Income
€ -4.46M€ -12.10M€ -2.41M
Net Income
€ -4.46M€ -12.02M€ -2.43M
Per Share Metrics
Basic EPS
€ -5.23€ -14.80€ -4.35
Diluted EPS
€ -5.23€ -14.80€ -4.35
Weighted Average Shares Outstanding
853.42K 813.32K 560.37K
Weighted Average Shares Outstanding (Diluted)
853.42K 813.32K 560.37K
Currency in EUR

Epigenomics Earnings and Revenue History